Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis

To compare the cost of two patient management strategies with similar efficacies for chronic inflammatory demyelinating polyneuropathy (CIDP) patients in the chronic phase: hospital-based IV immunoglobulin G (IVIg) and home-based subcutaneous immunoglobulin G (SCIg) associated with an interprofessio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one Jg. 15; H. 11; S. e0242630
Hauptverfasser:	Perraudin, Clémence, Bourdin, Aline, Vicino, Alex, Kuntzer, Thierry, Bugnon, Olivier, Berger, Jérôme
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Public Library of Science 25.11.2020 Public Library of Science (PLoS)
Schlagworte:	Analysis Biology and Life Sciences Chemotherapy Cost analysis Cost-Benefit Analysis Costs Demyelinating diseases Demyelination Drug dosages Drug therapy Economic aspects Health care costs Health insurance Home Care Services - economics Hospitals Humans IgG antibody Immunoglobulin G Immunoglobulins Immunoglobulins, Intravenous - administration & dosage Immunoglobulins, Intravenous - economics Inflammation Infusions, Subcutaneous Insurance Intravenous administration Intravenous immunoglobulins Maintenance Medication Therapy Management - economics Medicine and Health Sciences Neurosciences Optimization Patients People and Places Pharmaceutical sciences Pharmacy Polyneuropathies Polyneuropathy Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - economics Primary care Professionals Public health Social Sciences Switzerland Training Switzerland United States > US
ISSN:	1932-6203, 1932-6203
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!